McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?

McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-running customer relationship. McKesson’s share price has been trending higher, with a 30-day share price return of 6.5% and a 90-day move of 16.9%. The 1-year total shareholder return of 22.5% and 5-year total shareholder return of about 3.8x suggest that recent contract wins and distribution...